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INFLAMMATION: A QUARTER CENTURY OF PROGRESS 
JOHN C. HOUCK, PH.D. 
Research Foundation of Children's Hospital, Washington, D. C., U. S. A. 
This report summarizes the progress of studies on inflammation during the past quarter 
century; it is a personal overview of the most important and salient accomplishments in this 
field. Except for a few references to review articles and textbooks in the field' much of the 
literature surveyed is not cited. ' 
ACUTE INFLAMMATION 
Introduction 
In the late 1880s Cohnheim summarized almost 
all of what was known about the inflammatory 
response up to that time. Proceeding from the 
original premise of Celsus that inflammation is 
associated with four cardinal signs, he demon-
strated that three of these signs-redness, swell-
ing, and heat-result from the leakage of normally 
intravascular fluid into the injured, extravascular 
area. In a careful series of timed experiments, 
Cohnheim showed that the initial event of the 
acute inflammatory response is an increased per-
meability of the microcirculation followed by the 
infiltration of the formed elements of the blood 
into the injured area. Some 40 years later, Lewis 
suggested that an H substance (a histamine-like 
material) is an important mediator of this initial 
increase in permeability after injury. Immedi-
ately after World War II, the pharmaceutical 
industry undertook the task of developing selective 
and specific inhibitors of histamine to provide an 
element of control over the degree of the inflamma-
tory response. Detailed studies during the early 
1950s indicated, however, that histamine alone 
does not sufficiently explain how the permeability 
to local injury is mediated. During this time, the 
role of kinins, and more recently of prostaglandins, 
in increasing the permeability of the small vessels 
of the connective tissue was demonstrated. 
During the past quarter century, the major 
progress in understanding tissue reaction to injury 
has been to identify and characterize the mediators 
of the cellular response to injury and to determine 
the role of complement, kinins, and platelets in the 
inflammatory response. 
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Abbreviations: 
ADP: adenosine diphosphate 
B-cell: bone marrow-dependent cell 
LNPM: lymph-node permeability factor 
MAF: macrophage-activating factor 
MIF: migration-inhibitory factor 
PHA: phytohemagglutinin 
PMN: polymorphonuclear cell 
SRF: skin-reactive factor 
T-cell: thymus-dependent cell 
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Role of Complement 
According to Lewis, the purpose of the increased 
'permeability which characterizes the initial in-
flammatory response is to flood the injured area 
with "healing elements of the blood" and to dilute 
the irritants. Work by Mueller-Eberhart, Cochran, 
and Ward has shown that the most important of 
these "healing elements" are the sequence of 
interdigitated proenzymes and enzymes called 
complement, whose macromolecular components 
flood the injured area. Complement can best be 
explained by saying that the dozen or so proteins 
involved perform three major functions: (1) they 
identify the foreign material and sound the alarm; 
(2) the middle portions of the complement chain 
augment and amplify this alarm; and (3) the 
terminal portions become cytolytic in a specific 
manner. This cytolysis can destroy foreign cells, 
including bacteria, and in this sense complement 
represents the first line of defense of the host 
against injury. 
Cellular Infiltration 
Along with the activation of complement which 
eventually leads to cytolysis is the release of two 
peptides from the C3 and C5 portions of the 
amplification part of the complement chain. Dur-
ing the activation of each of these elements of 
complement via limited proteolysis, pep tides of 
about 5,000 daltons in size are released, which 
Ward and others have shown to be strongly chemo-
tactic for polymorphonuclear leukocytes. Thus, 
complement not only constitutes the first line of 
defense against injury but sounds a signal to 
recruit polymorphonuclear (PMN) cells into the 
defense system. These cells marginate to the small 
vessels, pass through the walls, and chemotacti-
cally migrate through the ground substance of the 
connective tissue to the site of injury. Since PMNs 
are capable of phagocytic activity, they contain 
specific organelles or lysosomes in which a wide 
variety of hydrolytic enzymes are stored. These 
organelles fuse with the vacuole formed during the 
phagocytic ingestion process and discharge their 
hydrolytic enzymes into what is known as the 
"garbage disposal" system of the cell. If the 
injurious agent makes a major break through the 
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epidermal and dermal barriers to infection, these 
phagocytic cells cannot handle the large numbers 
of invasive organisms; hence they "overeat" and 
die. The lytic enzymes, released from their lyso-
somes after death, introduce into the extracellular, 
extrafibular damaged area various soluble hydro-
lases which inactivate numerous toxic agents and 
digest some of the normal elements of the ground 
substance in situ. The products of this digestion 
are peptides of various sizes which are, of them-
selves, mildy chemotactic towards PMNs and 
macrophages. Thus, after the PMN "kamikaze" 
attack upon invasive organisms or other injurious 
agents, a signal brings the much more slowly 
moving macrophages into the injured area. These 
macrophages are far more adept at phagocytosis 
than the PMNs and represent the heavy guns 
employed in the second line of defense mounted by 
the host against invasion and injury. Kinetically, 
the increased permeability which characterizes 
inflammation is a matter of a few minutes at most; 
the infiltration of PMN s in to the injured area takes 
4 to 6 hr; and the infiltration of mononuclear cells, 
which are usually macrophagic, takes 12 to 24 hr. 
Thus, the normal consequence of the acute inflam-
matory response is first to flood the injured area 
with complement and then to infiltrate the area 
with phagocytic cells. 
Kinin Activation 
Because a wide variety of hydrolytic enzymes is 
released from the lysis of infiltrating PMNs, a 
limited hydrolysis of other macromolecular compo-
nents of both plasma and the ground substance 
occurs and activates the enzymes (kallikreins) 
involved in the release of bradykinin from bradyki-
ninogen . These enzymes, of which there are at least 
two, are inert zymogens which can be activated by 
several factors, including both surfaces and pro-
teases. This particular kinin increases the permea-
bility of the microcirculation and produces pain. 
Bradykinin is historically defined as the "pain-pro-
ducing peptide," a farily unique property among 
kin ins in general. 
Therefore, the four cardinal signs of Celsus 
scientifically and morphologically described by 
Cohnheim-pain, swelling, redness, and increased 
heat on the surface of the skin-result from the 
extravasation of normally circultaing macromole-
cules and fluid into the injured area. 
The primary mediators for the chemotactic 
stimulation of cell infiltration seem to be the 
peptide breakdown products which result from 
activation of the amplification portion of the 
I:omplement chain. The peptide breakdown prod-
'lcts from ground substance proteins, which are 
;1roduced by the lysosomal proteases and hydro-
ases brought into the injured area by PMNs, are 
iJSO chemotactic for macrophages. 
t hrombus Formation 
If the injury is sufficiently large to severely 
:estroy the micro architecture of the connective 
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tissue, components of collagen bundles and fibrils 
in the connective tissue often penetrate into the 
intraluminal space of the microcirculation in the 
injured area. As a consequence, platelets aggregate 
to the surface of these collagen fibrils or bundles 
and, in so doing, release several normally intracel-
lular materials, including serotonin and especially 
adenosine diphosphate (ADP). ADP establishes 
a gradient which causes other platelets to aggre-
gate to the platelets already adsorbed onto the 
surface of the collagen. Thus, a platelet throm-
bus is developed which occludes the microcircula-
tion into the injured area. When prothrombin is 
converted to thrombin, fibrinogen is enzymatically 
hydrolyzed to fibrin . The 6 polypeptide strands of 
fibrinogen have 1 bond in each of these strands 
broken towards the terminal end of the parent 
macromolecule ; this releases 3 moles of peptide A 
and 3 of peptide B. The residual macromolecule 
can then polymerize to form a clot, and peptide B 
has been demonstrated by Gladner to be synergis-
tic with bradykinin. In this fashion, the biologic 
continuity of the tissue is destroyed via a blockade 
in the capillary, venular, arterial, and lymphatic 
channels, and hemostasis is restored. Thus, by a 
combination ofthrombic blockage and polymeriza-
tion of fibrin to form a clot, the injured area is 
isolated from the circulation and becomes anoxic 
and ultimately acidotic. Acidosis proceeds from 
the fact that whereas the mitochondria cannot 
oxidize the products of glycolysis without oxygen, 
there is sufficient glycogen in the dermis and 
sufficient amylase available from the various cells 
in the skin to allow glycolysis and eventually the 
accumulation of large amounts of lactic and py-
ruvic acid in situ. As a consequence of anoxia and 
acidosis, ultimately the entire injured area be-
comes necrotic. 
All of these initial events take place within 24 to 
72 hr after injury. Experimentally we have found 
that it makes little difference what type of injury is 
inflicted-thermal, mechanical, chemical, immu-
nologic-or in which organ or species the imflam-
matory response is being studied. The mechanism 
by which tissues react to injury is not specific; 
that is, certain patterns of reaction to defend the 
host are followed regardless of the etiologic agent. 
Otherwise, during the course of evolution many 
species would have been destroyed by the develop-
ment of unique injurious agents. How much each 
of the various processes contributes quantitatively 
varies enormously, but qualitatively the patterns 
of permeability increase and cellular infiltration, 
with its concomitant changes and reactions, proba-
bly constitutes the initial phase of the acute in-
flammatory response. 
CHRONIC INFLAMMATION 
The chronic inflammatory response, in which 
the injurious agent is not easily disposed by 
phagocytosis, cytolysis, or sloughing, demonstrates 
basically the same pattern of response as described 
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above. Quantitatively, if the irritant is particles of 
silicon in the lung, the invading macrophages 
proliferate in situ at an enormous rate and be-
come permanently located in the tissue as his-
tiocytes. Eventually the chronic inflammatory 
agent is surrounded and encapsuled in fibrous 
connective tissue. If the injury is to the skin , the 
areas of the epidermis peripheral to the injurious 
agent begin to proliferate and, by means of a 
collagenolytic enzyme which they release, they 
penetrate beneath the injurious agent and isolate it 
from the surrounding tissue. Ultimately, this pro-
liferation of epidermal tissue causes the final 
induration and sloughing of the injurious material. 
If the injurious agents are located inside the host 
and cannot be sloughed from the external surfaces, 
caseation or enclosure of the inflammatory lesion 
by collagen and connective tissue takes place in a 
manner analogous to that which occurs in silicosis 
or tuberculosis. 
Role of Lymphocytes 
There is, however, an important difference be-
tween the immunologically mediated, chronic in-
flammatory response and the initial events of acute 
inflammation, namely, a delayed response to the 
injury and the involvement oflymphocytes. During 
the past quarter century, the study of delayed-type 
hypersensitivity has yielded much information 
which has been incorporated into the theoretical 
explanation of inflammation. Specifically, lym-
phocytes can be subclassifed into thymus-depend-
ent and bone marrow-dependent, or "T" and "B" 
cells, respectively, which perform two different 
functions. The T-cell is exclusively involved in 
delayed-type hypersensitivity , not in the synthesis 
of circulating antibody and immunoglobulins. The 
B-cell is not involved in delayed-type hypersensi-
tivity but, rather, is principally responsible for 
synthesizing serologic antibody. When each cell 
type is exposed to an antigen it can recognize, the 
T -cell transforms from a small lymphocyte to a 
large lymphoblast, synthesizing and releasing large 
amounts of extracellular mediators of delayed-type 
hypersensitivity called " lymphokines" ; B-cells , on 
the other hand, transform and release specific anti-
bodies. Antibodies are also thought to be released 
by transformed T-cells. These do not enter the cir-
culation as serologic antibody but are cytophilic in 
that they may attach themselves to the surface of 
the macrophages which they then direct to attack 
and destroy certain specific cells or materials via 
phagocytosis . Details of these responses are still 
not clear. Helper T-cells may be involved in B-cell 
transformation, and the distinction between B-
cells and T -cells may be affected by a thym us-
related hormone called thymosine. The role of 
opsonins in rendering materials subject to phago-
cytosis by macrophages and the ability of these 
cells to "process" the antigen before it can stimu-
late the lymphocyte are subtle points which re-
main to be definitively resolved. 
I 
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Delayed-type Hypersensitivity or Allergy 
It is experimentally clear that delayed-type 
hypersensitivity is mediated by intact lympho-
cytes and not by serologic factors, since sensitiv-
ity to a given antigen can be transferred only by the 
intact lymphocyte and not by the serum or plasma. 
The kinetic delay in the host's response to the 
appropriate antigen is probably due to the need to 
recruit and amplify the initial response of the 
sensitized lymphocytes to the challenging agent, 
all of which takes from 24 to 48 hr. 
Only recently have some of the important steps 
and their mediators for this type of immunologic 
reaction been determined and described. During 
the process of transforming a small lymphocyte 
(usually T-cell type) into a large lymphoblast 
either by antigens to which the cell has been 
previously sensitized or by lectins such as phytohe-
magglutinin (PHA) or poke weed mitogen, the cell 
synthesizes enormous amounts of DNA, RNA, and 
protein. Some of these proteins are of relatively 
small molecular weight and are specific mediators 
of many of the biologic events involved in delayed-
type hypersensitivity and inflammation . The cell-
free mediators of lymphocyte function in delayed-
type hypersensitivity are called lymphokines. A 
number of them have been identified by the 
biologic reactions they produce in vitro and in vivo. 
Role of Lymphokines 
Lymphotactin . When an animal which has been 
sensitized to a given antigen receives an interder-
mal injection of that antigen, one of the earliest 
responses is the infiltration oflymphocytes into the 
injected area. McCluskey has shown that within a 
day or so an enormous number of lymphocytes 
infiltrate into the injected area. These workers 
showed over 98 % of these infiltrated lymphocytes 
are not transformed by or responsive to the appro-
priate antigen. They therefore concluded that the 
few clones of " sophisticated" cells which recog-
nized the immunogen and were transformed by it 
released a mediator chemotactically attractive to 
other immunologically unsophisticated lympho-
cytes . In this fashion, the immunologic response to 
a given antigen would be enormously amplified by 
the recruitment of a large number of these unso-
phisticated cells into the response. Ward has 
shown that the supernatant fractions from cultures 
of transformed lymphocytes contained a material 
which was chemotactic for lymphocytes in vitro in 
a Boyden chamber. The normal chemotactic stim-
uli of PMNs and macrophages (i.e. , the peptides 
from the C3 and C5 portions of complement or even 
products of protein proteolysis) were not notice- · 
ably chemotactic for lymphocytes. We have found 
that aqueous extracts of thymus contain a material 
of molecular weight around 10,000 daltons which is 
thermolabile, destroyed by preincubation with 
either trypsin or neuraminidase, and which is 
specifically chemotactic for lymphocytes in vitro 
and in vivo. We have termed this material, which 
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we are in the process of purifying, "lymphotactin." 
When injected into the peritoneum of animals, this 
lymphokine produces an outpouring of mononu-
clear cells within 4 hr. Because of the action of 
lymphotactin, then, the degree of immunologic 
sophistication of lymphocytes is amplified since 
once these cells are chemotactically brought into 
the area of stimulated antigen, they and their 
daughter cells become sensitized to the particular 
antigen. 
Macrophage activation and migration-inhibitory 
factor. As the number of lymphocytes sensitized to 
a given antigen increases, the lymphokines re-
leased during their transformation also increase. 
Of particular importance is the macrophage migra-
tion-inhibitory factor (MIF) and the macrophage-
activating factor (MAF). The supernatants of 
transformed lymphocytes contain a material which 
inhibits the migration of macrophages in vitro and 
phagocytic ally activates these stationary and im-
mobilized cells. Biochemical measures of the in-
creased oxidation of carbohydrates to eventually 
form peroxides as well as other measures of phago-
cytosis are all increased when macrophages are 
exposed to the supernatants of immunologically or 
lectin-transformed lymphocytes. We have found 
that aqueous extracts of thymus contain a mac-
romolecule (mol wt, 36,500) which is trypsin-labile 
and neuraminidase-labile but thermostable and 
which inhibits the migration or'macrophages in 
vitro; when purified to the point of electrophoretic 
homogeneity , it is still able to activate these cells 
phagocytic ally . I believe that MIF is a secondary 
manifestation of the primary purpose of this lym-
phokine, namely to increase the phagocytic activ-
ity of these macrophages. Since MIF is not per se 
chemotactic to macrophages, other mechanisms 
must be involved in recruiting macrophages into 
the area. 
The glycoprotein MIF, which contains sialic acid 
and O-methyl glucopyranoside as its only carbohy-
drates, is extremely susceptible to proteolytic en-
zymes. Since macrophages supposedly dribble 
their digestive enzymes extracellularly while eat-
ing, this may be a mechanism for limiting the 
effects of MIF since these digestive enzymes effec-
tively and quickly destroy the mediator . Thus , 
MIF and MAF activity is maintained only in the 
presence of antigen and fresh lymphocytes. Once 
t he antigenic irritant is destroyed by phagocytosis, 
the mediator is quickly destroyed by proteolysis 
whereupon the macrophages relax into their post-
prandial dormant state and migrate in search of 
!lew "haute cuisine." 
Skin-reactive factor . Numerous other lympho-
<ines are believed to be released by transformed 
'ymphocytes in vitro and in vivo. Of these, only one 
s important and relevant to this report, namely, 
:he skin-reactive factor (SRF). Pick and Turk and, 
n an independent study, Bennett and Bloom have 
,·,hown that the supernatants of transformed lym-
.)hocytes contain a material which, when injected 
nto the skin of guinea pigs, produces a rapid and 
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severe induration of the injured site. This work is 
similar to the studies of Spector and Willoughby, 
who found by means of the "dermal bluing" 
technique that extracts of lymph nodes and other 
lymphoid tissues increase the permeability of the 
microcirculation. The lymphatic drainage in rat 
skin is so rapid that it is impossible to induce 
edema and induration in this species. Two effects 
of injecting the lymph-node permeability factor 
(LNPF) or SRF into the skin of either guinea pigs 
or rats are the increased permeability of the 
microcirculation which leads to edema where ap-
propriate and the infiltration of leukocytes into the 
injected area. Morphologic studies have indicated 
that the cell types involved in this infiltration are 
both polymorphonuclear and mononuclear. 
In attempting to isolate and purify this 
SRF-LNPF activity from lymph nodes, spleen, 
and the supernatant of transformed lymphocytes, 
we have found that all of the permeability-increas-
ing activity is concentrated in a molecular weight 
range of 50,000 to 100,000 daltons and at an 
isoelectric point of pH 4.2 during isoelectric focus-
ing. This activity can be purified to the level of 
homogeneity in gel electrophoresis by additional 
preparative acrylamide gel electrophoresis. These 
three tissues (lymph nodes, spleen, and trans-
formed lymphocytes) demonstrated basically the 
same kind of material in terms of molecular size, 
charge density, and isoelectric point which pro-
duced induration in guinea-pig skin and permea-
bility increases in rat skin. Interdermal injection of 
all three purified materials caused mononuclear 
cells and some granulocytes to infiltrate into the 
injected area. The fact that all of these purified 
materials digest hemoglobin at pH 3.0 in the 
absence of disulfide activation suggests that they 
contain cathepsin D-like enzyme. Moreover, when 
these purified lymphoid tissue extracts are treated 
with pepstatin, a powerful inhibitor of acid pro-
teases including cathepsin D, the effects of the 
SRF or LNPF purified preparations in vivo and 
their in vitro digestion of denatured hemoglobin 
are completely inhibited. Thus, we believe that 
transformed lymphoblasts release a cathepsin D-
like enzyme into the extravascular, extracellular, 
extrafibrillar space of the ground substance of the 
connective tissue. This acid protease can then act 
hydrolytically on the preexisting proteins in the 
ground substance, the products of which are 
chemotactic for macrophages and PMNs. 
Role of Acid Leukokinins 
Recently, Greenbaum has shown a kininogen in 
ascites fluid from which can be released, via 
cathepsin D activity, a new class of kinins, the acid 
leukokinins, which like other kinins increase the 
permeability of the microcirculation but otherwise 
differ chemically from them. Moreover, we have 
found in the ground substance of the skin a large 
amount of the same kininogen from which, via 
cathepsin D incubation or by incubation with SRF 
or LNPF, Greenbaum demonstrated the release of 
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acid leukokinin. Therefore, I suggest that the 
permeability increase characteristic of SRF or 
LNPF is the result of the ability of this cathepsin 
D-like enzyme to release acid leukokinin from its 
appropriate kininogen which exists as a preformed 
macromolecule in the ground substance. 
Therefore, lymphocytes, transformed by expo-
sure to antigens to which they were previously 
sensitized, release lymphotactin, which recruits a 
large number of unsophisticated lymphocytes into 
the immunologic defense system. As a result, large 
amounts of MAF and SRF are released into the 
antigen-containing area. The activation of macro-
phages is an attempt to phagocytic ally destroy the 
invading antigen. Cathepsin D-like SRF increases 
the permeability of the microcirculation in the area 
and chemotactically attracts some of the formed 
elements of the blood to infiltrate and to support 
the defense against the invading antigen. This 
whole series of events constitutes the principal 
immunologic defense mechanisms (other than cir-
culating antibody) against the invasion of the host 
by foreign antigens. 
Obviously, during the preceding quarter century 
we have deepened our understanding of the inflam-
matory response as the basic and initial mecha-
nism of the host's reaction to various injurious 
agents. During the last decade, much of the 
research has been aimed at determining the nature 
and role of complement in the inflammatory re-
sponse, the role of lysosomes in inflammation, and 
the characteristics of the various lymphokines 
which are now known to be the principal mediators 
of cell-mediated inflammation and immunity. The 
role of platelets, coagulation, and kin ins is also 
better understood since the biochemical mech-
anisms of their action and the degree of their 
involvement in the inflammatory response have 
been elucidated. 
What does the future hold? Where do we go from 
here? It would be presumptuous of me to prognos-
ticate, but clearly pharmacologic control of the 
inflammatory response must become more sophis-
ticated as a result of our increased knowledge of the 
mechanisms and mediators of the inflammatory 
response. Specifically, membranes should be sta-
bilized so that lysosomal rupture, platelet aggrega-
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tion, and chemotactic migration cannot take place. 
Furthermore, the development of inhibitors of 
lymphocyte transformation to prevent the release 
of lymphokines would help to control the inflam-
matory response produced by delayed-type hyper-
sensitivity and the graft-rejection phenomena. Fi-
nally, if specific chemical inhibitors of the various 
lymphokines could be developed, particularly lym-
photactin, MAF, and SRF-LNPF, not only the 
chronic inflammatory response to autoantigens but 
also tissue destruction would be inhibited. Inhibi-
tion of cathepsin D and other lysosomal proteases 
certainly delimits the tissue destruction associated 
with inflammation. We have recently found, for 
example, that acetylated 5-amino valerie acid is a 
potent inhibitor of MIF or MAF activity in vitro. 
This compound is also a modestly effective, non-
steroidal, anti-inflammatory drug against adju-
vant arthritis in vivo. All of this suggests that 
Willoughby was correct when he stated that the 
ultimate pharmacologic control of the inflamma-
tory response may be a "cocktail" made up of 
numerous inhibitors of the various specific cellular 
and extracellular events involved in the inflamma-
tory response. Since inflammation is one of the 
most important basic biologic events in clinical 
medicine, its control by drugs will probably be 
vigorously researched during the next quarter cen-
tury. 
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